HEPATIC NEUROENDOCRINE TUMOUR

HEPATIC NEUROENDOCRINE TUMOUR was reported 37 times

These drug classes are most commonly taken by patients reporting HEPATIC NEUROENDOCRINE TUMOUR:

# Drug Count
0 Kinase Inhibitor [EPC] 5
1 mTOR Inhibitor Immunosuppressant [EPC] 5
2 Angiotensin Converting Enzyme Inhibitor [EPC] 4
3 Aromatase Inhibitor [EPC] 4
4 Corticosteroid [EPC] 4
5 Angiotensin 2 Receptor Blocker [EPC] 3
6 Anti-epileptic Agent [EPC] 3
7 Integrin Receptor Antagonist [EPC] 3
8 Mood Stabilizer [EPC] 3
9 Nucleoside Metabolic Inhibitor [EPC] 3
10 P2Y12 Platelet Inhibitor [EPC] 3
11 Somatostatin Analog [EPC] 3
12 Alkylating Drug [EPC] 2
13 Calcium [EPC] 2
14 GLP-1 Receptor Agonist [EPC] 2
15 Hepatitis C Virus NS5A Inhibitor [EPC] 2
16 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 2
17 Interferon beta [EPC] 2
18 Nonsteroidal Anti-inflammatory Drug [EPC] 2
19 Platelet Aggregation Inhibitor [EPC] 2
20 Proton Pump Inhibitor [EPC] 2
21 Provitamin D2 Compound [EPC] 2
22 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 2
23 Catecholamine [EPC] 1
24 Endoglycosidase [EPC] 1
25 Folate Analog Metabolic Inhibitor [EPC] 1
26 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
27 Glucosylceramide Synthase Inhibitor [EPC] 1
28 Insulin Analog [EPC] 1
29 Interleukin-4 Receptor alpha Antagonist [EPC] 1
30 Janus Kinase Inhibitor [EPC] 1
31 Microtubule Inhibitor [EPC] 1
32 Neonatal Fc Receptor Blocker [EPC] 1
33 Opioid Agonist [EPC] 1
34 Osmotic Laxative [EPC] 1
35 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
36 Phosphodiesterase 5 Inhibitor [EPC] 1
37 Platinum-based Drug [EPC] 1
38 Serotonin-3 Receptor Antagonist [EPC] 1
39 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
40 Thiazide Diuretic [EPC] 1
41 Topoisomerase Inhibitor [EPC] 1
42 Vitamin B12 [EPC] 1
43 Vitamin C [EPC] 1
44 Vitamin D [EPC] 1
45 alpha-Adrenergic Agonist [EPC] 1
46 beta-Adrenergic Agonist [EPC] 1